Yet another COVID-19 treatment has emerged, but is interferon lambda the miracle cure the world has been waiting for?
Summary of Key Points
- Currently available COVID-19 treatments have limitations and concerns.
- A new clinical trial shows promise for interferon lambda, effective against all variants and drops viral loads faster than other COVID-19 treatments.
- Interferon lambda is a “one-and-done” treatment.
- Interferon lambda has little interaction with other drugs, making it a safer treatment option for many individuals.
- The Food and Drug Administration has not approved interferon lambda as a COVID-19 treatment; emergency use authorization is still pending.
Limitations and Concerns With Current COVID-19 Treatments
The currently available treatments for COVID-19 have been far from perfect, with each presenting its limitations and concerns.For instance, questions have been raised about the safety and effectiveness of Molnupiravir, while Paxlovid is associated with a high number of cross-drug interactions, and there are concerns about managing rebound syndrome.
